GlassScriptPhysician profile
Makram Hajj
NPI 1194782698
$3,986.95
in general payments reported to CMS, 2019-2025
21 companies · $902 in 2025
The $902 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $77.82 · 2021: $184 · 2023: $2,080 · 2024: $372 · 2025: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,767 · Travel and Lodging: $1,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,766.92 |
| Travel and Lodging | $1,587.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,979.10 | 2023 | Watchman Access System |
| Alnylam Pharmaceuticals INC. | $339.36 | 2025 | Amvuttra |
| Amgen INC. | $276.68 | 2023-2025 | Repatha, Repatha |
| Abbott Laboratories | $248.73 | 2021-2025 | Cardiomems, Diamondback Coronary, Coroflow |
| Astrazeneca Pharmaceuticals LP | $216.89 | 2019-2025 | Brilinta |
| Pfizer INC. | $195.02 | 2019-2025 | |
| Ge Healthcare | $120.00 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $101.10 | 2019-2024 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.68 | 2019 | |
| Irhythm Technologies, INC. | $62.04 | 2024 | Zio Monitor, Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.58 | 2024-2025 | Lifevest |
| Teleflex LLC | $54.02 | 2025 | Guideliner, Turnpike |
| Lantheus Medical Imaging, INC. | $52.91 | 2019-2020 | |
| Medtronic, INC. | $35.77 | 2021-2023 | Onyx Frontier |
| Edwards Lifesciences Corporation | $27.75 | 2025 | Sapien 3 Ultra Resilia |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $25.30 | 2025 | |
| Kestra Medical Technology Services, INC. | $23.79 | 2024 | Assure Wcd |
| Terumo Medical Corporation | $21.17 | 2019 | |
| Cordis US Corp. | $20.89 | 2024 | Mynx Venous Vcd |
| Elutia, INC. | $15.00 | 2021 | |
| Medtronic Vascular, INC. | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Makram Hajj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.